ClinicalTrials.gg
RecruitingNCT07277517Updated Apr 3, 2026

The Effect of Integrating Pain Neuroscience Education(PNE) With Conventional Physiotherapy on Pain and Functional Disability in Patients With Acute Low Back Pain

An interventional study of routine physiotherapy + traditional patient education and pain neuroscience education in Acute Low-back Pain, sponsored by Iran University of Medical Sciences. Recruiting at 1 site in Iran. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-03.

Sponsored by Iran University of Medical Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Oct 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Acute low back pain is one of the most common health problems in the world. Most people experience it at least once in their lives, and although many cases improve within a few weeks, a significant number of patients continue to struggle with pain, fear of movement, stress, and reduced daily function. These psychological factors-such as catastrophizing ("my back is damaged"), fear of movement ("if I move, it gets worse"), and avoidance behaviors-can slow recovery and increase the risk of the pain becoming chronic.

Pain Neuroscience Education (PNE) is a modern educational approach that teaches patients how pain actually works in the nervous system. Instead of focusing only on muscles and bones, PNE helps people understand how the brain interprets pain, why pain can persist even without serious injury, and how thoughts, emotions, and behaviors can influence the experience of pain. Research shows that PNE can reduce fear, improve movement, and help people participate better in rehabilitation-especially in chronic pain. However, there is very limited high-quality evidence about its effects in acute low back pain.

The purpose of this study is to determine whether adding Pain Neuroscience Education to routine physiotherapy can improve recovery in people with acute low back pain.

To do this, the investigators will conduct a single-blind randomized clinical trial with two groups of patients:

Control group: Receives conventional physiotherapy, including soft-tissue mobilization and TENS, along with routine patient education about posture and back care.

Intervention group: Receives the same physiotherapy plus two structured sessions of Pain Neuroscience Education, delivered individually using simple explanations, metaphors, and visual materials.

Both groups will receive eight treatment sessions over four weeks.

The investigators will measure several important outcomes before starting treatment and immediately after the 8th session, including:

Pain intensity

Functional disability

Pain catastrophizing

Fear-avoidance beliefs

Fear of movement (kinesiophobia)

The investigators' hypothesis is that patients who receive PNE in addition to routine physiotherapy will show greater reductions in pain, disability, fear, and catastrophizing compared to those receiving physiotherapy alone.

If proven effective, this approach could provide a simple, low-cost, and safe addition to physiotherapy that not only reduces pain but also prevents acute low back pain from turning into a chronic condition. This could help improve patients' quality of life and reduce the economic and healthcare burden caused by low back pain.

02

Conditions studied

  • Acute Low-back Pain

Browse trials for

03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 48 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Iran University of Medical Sciences is the lead sponsor of 25 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years and older.
  • A primary complaint of acute low back pain (defined as pain between the bottom of the ribs and the gluteal fold), with or without leg pain.
  • Pain duration of less than 6 weeks.
  • Absence of any "red flags" for serious spinal pathology (e.g., tumor, infection, fracture, cauda equina syndrome), as confirmed by an orthopedist or neurologist.

Exclusion criteria

Exclusion Criteria:

  • Low back pain lasting more than 3 months (chronic low back pain).
  • History of spinal surgery within the past 3 years.
  • Inability to read or understand Persian.
  • Diagnosed cognitive impairments.
  • Unwillingness to continue the treatment or study protocol.
  • Diagnosed rheumatic, neurological, cardiac, metabolic, or respiratory diseases.
  • Diagnosis of fibromyalgia, chronic fatigue syndrome, loss of skin sensation, or skin inflammation/swelling in the low back area.
  • Presence or emergence of any "red flag" condition.
  • Missing more than 3 consecutive treatment sessions.
  • Previous participation in Pain Neuroscience Education sessions.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    "Conventional Physiotherapy Plus Pain Neuroscience Education (PNE)"

    Other: routine physiotherapy + traditional patient education · Behavioral: pain neuroscience education

  • Active comparator
    "Conventional Physiotherapy With Routine Back-Care Education"

    Other: routine physiotherapy + traditional patient education

Interventions

  • Otherroutine physiotherapy + traditional patient education

    Conventional Physiotherapy (Control Group) Participants in the control group will receive a baseline physiotherapy protocol, administered twice weekly for four weeks (8 sessions total). Each session includes: Soft Tissue Mobilization (40 minutes): Four specific myofascial release techniques targeting the low back and pelvic muscles (e.g., transverse sliding of lumbar muscles, thoracolumbar fascia release, quadratus lumborum release, iliopsoas release). Transcutaneous Electrical Nerve Stimulation (TENS) (30 minutes): Applied crosswise over the low back with parameters set at 100 Hz frequency and 300 µs pulse width, adjusted to a strong but comfortable sensory level. Additionally, this group receives two individual 50-minute sessions of standard physical hygiene and routine back care education to control for the time and attention given to the experimental group's Pain Neuroscience Education.

  • Behavioralpain neuroscience education

    The experimental group receives the same conventional physiotherapy as the control group, with the addition of PNE. This consists of two individual, face-to-face educational sessions (40-50 minutes each), delivered before the first and after the last physiotherapy session. The curriculum is based on established resources ("Explain Pain" and "Pain Neuroscience Education: Teaching People About Pain") and uses metaphors, examples, and slides to reconceptualize pain by explaining neurobiology, central sensitization, and the distinction between pain and tissue injury. Understanding is assessed using the revised Neurophysiology of Pain Questionnaire (rNPQ), and participants receive a booklet for reinforced learning at home.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    Pain intensity was assessed using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 to 10, where 0 indicates no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity.

    Time frame: first session (day 1), end of 8th session (4 weeks)

  2. Oswestwry Disability Index

    Functional disability was assessed using the Oswestry Disability Index (ODI), a questionnaire scored from 0 to 100%, where 0 indicates no disability and 100 indicates maximum disability. Higher scores reflect greater levels of disability.

    Time frame: first session (day 1), end of 8th session (4 weeks)

Secondary outcomes

  1. Tampa Scale Of Kinesiophobia

    Kinesiophobia was assessed using the Tampa Scale of Kinesiophobia (TSK), a questionnaire with scores ranging from 17 to 68. Higher scores indicate greater fear of movement, with scores of 38 or above considered indicative of high kinesiophobia.

    Time frame: first session (day 1), end of 8th session (4 weeks)

  2. Fear Avoidance Beliefs Questionnaire

    Fear-avoidance beliefs were assessed using the Fear-Avoidance Beliefs Questionnaire (FABQ), which evaluates beliefs about how physical activity and work may affect pain and disability. The questionnaire consists of two subscales (physical activity and work), with higher scores indicating stronger fear-avoidance beliefs.

    Time frame: first session (day 1), end of 8th session (4 weeks)

  3. Pain Catastrophizing Scale

    Pain catastrophizing was assessed using the Pain Catastrophizing Scale (PCS), a questionnaire with a total score ranging from 0 to 52. Higher scores indicate greater levels of catastrophic thinking related to pain.

    Time frame: first session (day 1), end of 8th session (4 weeks)

07

Study locations

1 of 1 sites recruiting
  • rehabilitation facility, Iran university of medical science
    Tehran, Iran
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Apr 2026, 6 months after the start.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 6 months is below that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2025
First posted
Dec 11, 2025
StartActual
Oct 5, 2025
Primary completionEst.
Apr 2026
CompletionEst.
Aug 2026
Last update
Apr 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07277517
Lead sponsor
Iran University of Medical Sciences
Responsible party
Sponsor
First posted
Dec 11, 2025
Start date
Oct 5, 2025
Primary completion
Apr 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Apr 3, 2026

Study contacts

Mohammadreza Pourahmadi
Contact
pourahmadipt@gmail.com
00989122245593

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion